BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 25470237)

  • 1. Setting up a wide panel of patient-derived tumor xenografts of non-small cell lung cancer by improving the preanalytical steps.
    Ilie M; Nunes M; Blot L; Hofman V; Long-Mira E; Butori C; Selva E; Merino-Trigo A; Vénissac N; Mouroux J; Vrignaud P; Hofman P
    Cancer Med; 2015 Feb; 4(2):201-11. PubMed ID: 25470237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors.
    Wang D; Pham NA; Tong J; Sakashita S; Allo G; Kim L; Yanagawa N; Raghavan V; Wei Y; To C; Trinh QM; Starmans MH; Chan-Seng-Yue MA; Chadwick D; Li L; Zhu CQ; Liu N; Li M; Lee S; Ignatchenko V; Strumpf D; Taylor P; Moghal N; Liu G; Boutros PC; Kislinger T; Pintilie M; Jurisica I; Shepherd FA; McPherson JD; Muthuswamy L; Moran MF; Tsao MS
    Int J Cancer; 2017 Feb; 140(3):662-673. PubMed ID: 27750381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-derived xenografts from non-small cell lung cancer brain metastases are valuable translational platforms for the development of personalized targeted therapy.
    Lee HW; Lee JI; Lee SJ; Cho HJ; Song HJ; Jeong DE; Seo YJ; Shin S; Joung JG; Kwon YJ; Choi YL; Park WY; Lee HM; Seol HJ; Shim YM; Joo KM; Nam DH
    Clin Cancer Res; 2015 Mar; 21(5):1172-82. PubMed ID: 25549722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of siRNA Silencing of TUG1 and LCAL6 Long Non-coding RNAs on Patient-derived Xenograft of Non-small Cell Lung Cancer.
    Fang T; Huang H; Li X; Liao J; Yang Z; Hoffman RM; Cheng XI; Liang L; Hu W; Yun S
    Anticancer Res; 2018 Jan; 38(1):179-186. PubMed ID: 29277771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of patient-derived non-small cell lung cancer xenograft models with genetic aberrations within EGFR, KRAS and FGFR1: useful tools for preclinical studies of targeted therapies.
    Zhang XC; Zhang J; Li M; Huang XS; Yang XN; Zhong WZ; Xie L; Zhang L; Zhou M; Gavine P; Su X; Zheng L; Zhu G; Zhan P; Ji Q; Wu YL
    J Transl Med; 2013 Jul; 11():168. PubMed ID: 23842453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translating the therapeutic potential of AZD4547 in FGFR1-amplified non-small cell lung cancer through the use of patient-derived tumor xenograft models.
    Zhang J; Zhang L; Su X; Li M; Xie L; Malchers F; Fan S; Yin X; Xu Y; Liu K; Dong Z; Zhu G; Qian Z; Tang L; Schöttle J; Zhan P; Ji Q; Kilgour E; Smith PD; Brooks AN; Thomas RK; Gavine PR
    Clin Cancer Res; 2012 Dec; 18(24):6658-67. PubMed ID: 23082000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-derived non-small cell lung cancer xenograft mirrors complex tumor heterogeneity.
    Chen X; Shen C; Wei Z; Zhang R; Wang Y; Jiang L; Chen K; Qiu S; Zhang Y; Zhang T; Chen B; Xu Y; Feng Q; Huang J; Zhong Z; Li H; Che G; Xiao K
    Cancer Biol Med; 2021 Feb; 18(1):184-198. PubMed ID: 33628593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-derived xenografts of non-small-cell lung cancer: a pre-clinical model to evaluate adjuvant chemotherapy?
    Merk J; Rolff J; Becker M; Leschber G; Fichtner I
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):454-9. PubMed ID: 19502076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ability to form primary tumor xenografts is predictive of increased risk of disease recurrence in early-stage non-small cell lung cancer.
    John T; Kohler D; Pintilie M; Yanagawa N; Pham NA; Li M; Panchal D; Hui F; Meng F; Shepherd FA; Tsao MS
    Clin Cancer Res; 2011 Jan; 17(1):134-41. PubMed ID: 21081655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor characteristics associated with engraftment of patient-derived non-small cell lung cancer xenografts in immunocompromised mice.
    Chen Y; Zhang R; Wang L; Correa AM; Pataer A; Xu Y; Zhang X; Ren C; Wu S; Meng QH; Fujimoto J; Jensen VB; Antonoff MB; Hofstetter WL; Mehran RJ; Pisimisis G; Rice DC; Sepesi B; Vaporciyan AA; Walsh GL; Swisher SG; Roth JA; Heymach JV; Fang B
    Cancer; 2019 Nov; 125(21):3738-3748. PubMed ID: 31287557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organoid Cultures as Preclinical Models of Non-Small Cell Lung Cancer.
    Shi R; Radulovich N; Ng C; Liu N; Notsuda H; Cabanero M; Martins-Filho SN; Raghavan V; Li Q; Mer AS; Rosen JC; Li M; Wang YH; Tamblyn L; Pham NA; Haibe-Kains B; Liu G; Moghal N; Tsao MS
    Clin Cancer Res; 2020 Mar; 26(5):1162-1174. PubMed ID: 31694835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancer.
    Hao C; Wang L; Peng S; Cao M; Li H; Hu J; Huang X; Liu W; Zhang H; Wu S; Pataer A; Heymach JV; Eterovic AK; Zhang Q; Shaw KR; Chen K; Futreal A; Wang M; Hofstetter W; Mehran R; Rice D; Roth JA; Sepesi B; Swisher SG; Vaporciyan A; Walsh GL; Johnson FM; Fang B
    Cancer Lett; 2015 Feb; 357(1):179-185. PubMed ID: 25444907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung mesenchymal cells function as an inductive microenvironment for human lung cancer propagating cells†.
    Ampollini L; Madeddu D; Falco A; Frati C; Lorusso B; Graiani G; Saccani F; Gervasi A; Rossetti P; Bonomini S; Gnetti L; Lagrasta CA; Silini EM; Quaini E; Petronini P; Alfieri R; Rusca M; Carbognani P; Quaini F
    Eur J Cardiothorac Surg; 2014 Dec; 46(6):e103-12. PubMed ID: 25312525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Influence of Tissue Ischemia Time on RNA Integrity and Patient-Derived Xenografts (PDX) Engraftment Rate in a Non-Small Cell Lung Cancer (NSCLC) Biobank.
    Guerrera F; Tabbò F; Bessone L; Maletta F; Gaudiano M; Ercole E; Annaratone L; Todaro M; Boita M; Filosso PL; Solidoro P; Delsedime L; Oliaro A; Sapino A; Ruffini E; Inghirami G
    PLoS One; 2016; 11(1):e0145100. PubMed ID: 26731692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of a platform of non-small-cell lung cancer patient-derived xenografts with clinical and genomic annotation.
    Kang HN; Choi JW; Shim HS; Kim J; Kim DJ; Lee CY; Hong MH; Park SY; Park AY; Shin EJ; Lee SY; Pyo KH; Yun MR; Choi HM; Lee SS; Kim SY; Lee H; Paik S; Cho BC; Lee JG; Kim HR
    Lung Cancer; 2018 Oct; 124():168-178. PubMed ID: 30268457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical assessment of cisplatin-based therapy versus docetaxel-based therapy on a panel of human non-small-cell lung cancer xenografts.
    Némati F; Bras-Gonçalves R; Fontaine JJ; de Pinieux G; De Cremoux P; Chapelier A; Daniel C; Laurent-Puig P; Livartowski A; Judde JG; Bordier V; Poupon MF; Decaudin D
    Anticancer Drugs; 2009 Nov; 20(10):932-40. PubMed ID: 19741504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Establishment and its biological characteristics of patient-derived lung cancer xenograft models].
    Zhuo Y; Wu Y; Guo A; Chen S; Su J
    Zhongguo Fei Ai Za Zhi; 2010 Jun; 13(6):568-74. PubMed ID: 20681441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal cancer patient-derived xenografted tumors maintain characteristic features of the original tumors.
    Cho YB; Hong HK; Choi YL; Oh E; Joo KM; Jin J; Nam DH; Ko YH; Lee WY
    J Surg Res; 2014 Apr; 187(2):502-9. PubMed ID: 24332554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathology of non-small cell lung cancer. New diagnostic approaches.
    Linnoila I
    Hematol Oncol Clin North Am; 1990 Dec; 4(6):1027-51. PubMed ID: 1962774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and characterization of human non-small cell lung cancer cell lines.
    Li J; Yang H; Chen L; Li Y; Zhu Y; Dai Y; Chen K; Ai J; Zeng T; Mao X; Liu L; Li X; Guan XY
    Mol Med Rep; 2012 Jan; 5(1):114-7. PubMed ID: 21971914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.